TERESA A ANTALEK

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family ENDWELL, NY NPI 1457790370

General Payments — all program years on this page

$2,934.51

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 138
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $849.38 across 43 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $849.3843

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $429.6414
2022 $698.2837
2023 $957.2144
2024 $849.3843

Records — PY2024 (43)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078108260 Janssen Pharmaceuticals, Inc $24.78 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100335242 Novo Nordisk Inc $16.35 10/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100431665 Novo Nordisk Inc $17.75 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100475893 Novo Nordisk Inc $14.78 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104219883 AstraZeneca Pharmaceuticals LP $16.66 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104288026 AstraZeneca Pharmaceuticals LP $15.00 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106445868 ABBVIE INC. $20.69 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106445870 ABBVIE INC. $28.92 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106445872 ABBVIE INC. $9.20 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106445874 ABBVIE INC. $18.52 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106445876 ABBVIE INC. $24.91 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106445878 ABBVIE INC. $9.50 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106445880 ABBVIE INC. $22.95 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106445882 ABBVIE INC. $32.89 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106445884 ABBVIE INC. $10.36 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106445886 ABBVIE INC. $25.49 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106445888 ABBVIE INC. $25.66 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106445890 ABBVIE INC. $29.61 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106445892 ABBVIE INC. $29.16 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106445894 ABBVIE INC. $34.50 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106445896 ABBVIE INC. $4.43 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106445898 ABBVIE INC. $28.74 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106445900 ABBVIE INC. $31.05 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106445902 ABBVIE INC. $11.20 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115987122 GlaxoSmithKline, LLC. $18.47 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116556027 GlaxoSmithKline, LLC. $20.53 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116628410 GlaxoSmithKline, LLC. $14.63 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116652437 GlaxoSmithKline, LLC. $13.09 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117495504 Amgen Inc. $18.61 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117495506 Amgen Inc. $20.97 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125076894 Abbott Laboratories $20.73 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125076896 Abbott Laboratories $23.93 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125076898 Abbott Laboratories $20.03 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125076900 Abbott Laboratories $14.59 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131128783 PFIZER INC. $18.67 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131824900 PFIZER INC. $17.67 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135924190 Lilly USA, LLC $22.98 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135979092 Lilly USA, LLC $13.52 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150989024 Neurocrine Biosciences, Inc. $18.18 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151145484 Phathom Pharmaceuticals, Inc. $17.41 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151145486 Phathom Pharmaceuticals, Inc. $17.41 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151145488 Phathom Pharmaceuticals, Inc. $17.41 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153389408 Dexcom, Inc. $17.45 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.